Doron Zahger

Author PubWeight™ 69.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012 18.18
2 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011 13.10
3 Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial. Am Heart J 2006 1.61
4 Plasma level of N terminal pro-brain natriuretic peptide as a prognostic marker in critically ill patients. Anesth Analg 2006 1.59
5 Benefit of direct ambulance to coronary care unit admission of acute myocardial infarction patients undergoing primary percutaneous intervention. Int J Cardiol 2006 1.55
6 Impact of the metabolic syndrome on the clinical outcomes of non-clinically diagnosed diabetic patients with acute coronary syndrome. Am J Cardiol 2007 1.50
7 Incidence, risk factors, management and outcomes of coronary artery perforation during percutaneous coronary intervention. Am J Cardiol 2009 1.42
8 Ultra-short-term heart rate variability for early risk stratification following acute ST-elevation myocardial infarction. Cardiology 2009 1.41
9 Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation. Int J Cardiol 2005 1.39
10 Predictors of high-risk angiographic findings in patients with non-ST-segment elevation acute coronary syndrome. Catheter Cardiovasc Interv 2013 1.39
11 Psoriasis and the metabolic syndrome. Acta Derm Venereol 2007 1.16
12 Cell free DNA detected by a novel method in acute ST-elevation myocardial infarction patients. Acute Card Care 2010 1.04
13 Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial. Lancet 2003 1.02
14 Euro Heart Survey 2009 Snapshot: regional variations in presentation and management of patients with AMI in 47 countries. Eur Heart J Acute Cardiovasc Care 2013 0.96
15 [ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)]. G Ital Cardiol (Rome) 2012 0.95
16 Propofol infusion syndrome: a rare cause of multi-organ failure in a man with complicated myocardial infarction. Isr Med Assoc J 2008 0.93
17 Contemporary treatment and adherence to guidelines in women and men with acute coronary syndromes. Int J Cardiol 2008 0.93
18 Routine laboratory results and thirty day and one-year mortality risk following hospitalization with acute decompensated heart failure. PLoS One 2010 0.93
19 Computerized community cholesterol control (4C): meeting the challenge of secondary prevention. Isr Med Assoc J 2009 0.91
20 Incidence, predictors and outcome of upper gastrointestinal bleeding in patients with acute coronary syndromes. Int J Cardiol 2011 0.87
21 The significance of new onset atrial fibrillation complicating acute myocardial infarction. Clin Res Cardiol 2011 0.86
22 The implementation of guidelines and prognosis among patients with acute coronary syndromes is influenced by physicians' perception of antecedent physical and cognitive status. Cardiology 2007 0.85
23 Impact of the community's socioeconomic status on characteristics and outcomes of patients undergoing percutaneous coronary intervention. Int J Cardiol 2009 0.85
24 B-type natruiretic peptide levels stratify the risk for arrhythmia among implantable cardioverter defibrillator patients. Clin Cardiol 2008 0.81
25 Reperfusion arrhythmias during coronary angioplasty for acute myocardial infarction predict ST-segment resolution. Coron Artery Dis 2003 0.81
26 Comparison of thrombolysis in myocardial infarction, Global Registry of Acute Coronary Events, and Acute Physiology and Chronic Health Evaluation II risk scores in patients with acute myocardial infarction who require mechanical ventilation for more than 24 hours. Am J Cardiol 2011 0.80
27 Grade 3 ischemia on the admission electrocardiogram predicts failure of ST resolution and of adequate flow restoration after primary percutaneous coronary intervention for acute myocardial infarction. Am Heart J 2007 0.80
28 [Trends in management, morbidity and mortality of patients with acute myocardial infarction hospitalized in the last decade]. Harefuah 2006 0.80
29 Real-World Use of Novel P2Y12 Inhibitors in Patients with Acute Myocardial Infarction: A Treatment Paradox. Cardiology 2016 0.80
30 Aspirin, warfarin and a thienopyridine for acute coronary syndromes. Cardiology 2005 0.79
31 Age differences in the adherence to treatment guidelines and outcome in patients with ST-elevation myocardial infarction. Arch Gerontol Geriatr 2010 0.78
32 Door to balloon and door to needle: temporal trends in delays to reperfusion. Isr Med Assoc J 2003 0.78
33 The chest pain unit: doing it right or overdoing it? Isr Med Assoc J 2010 0.78
34 Predicting survival with reperfusion arrhythmias during primary percutaneous coronary intervention for acute myocardial infarction. Isr Med Assoc J 2007 0.78
35 Thrombocytopenia, immunoglobulin treatment, and acute myocardial infarction--a case report. Angiology 2005 0.77
36 Predictors and outcomes associated with radial versus femoral access for intervention in patients with acute coronary syndrome in a real-world setting: results from the Acute Coronary Syndrome Israeli Survey (ACSIS) 2010. J Invasive Cardiol 2014 0.77
37 Grade 3 ischemia on admission and absence of prior beta-blockade predict failure of ST resolution following thrombolysis for anterior myocardial infarction. Int J Cardiol 2005 0.77
38 Soroka acute myocardial infarction (SAMI) score predicting 10-year mortality following acute myocardial infarction. Int J Cardiol 2012 0.77
39 A new risk score predicting 1- and 5-year mortality following acute myocardial infarction Soroka Acute Myocardial Infarction (SAMI) Project. Int J Cardiol 2010 0.76
40 Efficacy of the radial approach for the performance of primary PCI for STEMI. J Invasive Cardiol 2013 0.76
41 Prior chronic clopidogrel therapy is associated with increased adverse events and early stent thrombosis. Thromb Haemost 2015 0.76
42 Insufficient compliance with current implantable cardioverter defibrillator (ICD) therapy guidelines in post myocardial infarction patients is associated with increased mortality. Int J Cardiol 2011 0.76
43 Prior heart failure among patients with acute coronary syndromes is associated with a higher incidence of in-hospital heart failure. Acute Card Care 2006 0.75
44 Trends in management, hospital and long-term outcomes of elderly patients with acute myocardial infarction. Am J Med 2007 0.75
45 N-acetylcysteine and contrast-induced nephropathy. N Engl J Med 2006 0.75
46 Letter by Porath et al regarding article, "Influence of inpatient service specialty on care processes and outcomes for patients with non-ST-segment elevation acute coronary syndromes". Circulation 2008 0.75
47 Reperfusion arrhythmias and ST-segment resolution. Am J Cardiol 2004 0.75
48 Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 2003 0.75
49 Grade of ischemia to assess no reflow after reperfusion. J Am Coll Cardiol 2010 0.75
50 Management and prevention of thrombotic stent occlusion. Eur Heart J 2005 0.75
51 Coronary artery stenting in patients treated by clopidogrel without aspirin. Int J Cardiol 2008 0.75
52 What have the new definition of acute myocardial infarction and the introduction of troponin measurement done to the coronary care unit? Impacts on admission rate, length of stay, case mix and mortality. Cardiology 2004 0.75
53 Contemporary use and outcome of percutaneous coronary interventions in patients with acute coronary syndromes: insights from the 2010 ACSIS and ACSIS-PCI surveys. EuroIntervention 2012 0.75
54 [Diabetics with normal coronary arteries: clinical features and prognosis]. Harefuah 2006 0.75
55 ST-elevation myocardial infarction caused by coronary artery compression due to localized pericardial hematoma caused by coronary perforation. J Invasive Cardiol 2010 0.75
56 [The use of cardiac troponins in acute coronary syndromes]. Harefuah 2003 0.75
57 Ventricular fibrillation as the presenting manifestation of adrenocortical carcinoma. Am Heart Hosp J 2009 0.75
58 Can enoxaparin safely replace unfractionated heparin during coronary intervention in acute coronary syndromes? Int J Cardiol 2004 0.75
59 Gender and ethnic disparities in outcome following acute myocardial infarction among Bedouins and Jews in southern Israel. Eur J Public Health 2010 0.75
60 Isolated inferior wall ST segment depression as an early sign of acute anterior wall myocardial infarction. Acute Card Care 2010 0.75
61 [A new definition for acute myocardial infarction]. Harefuah 2004 0.75
62 [The new universal definition of myocardial infarction]. Harefuah 2009 0.75
63 High-frequency QRS analysis in patients with acute myocardial infarction: a preliminary study. Ann Noninvasive Electrocardiol 2012 0.75
64 Severe reversible left ventricular dysfunction induced by carbon monoxide intoxication. Am J Emerg Med 2002 0.75
65 [Brain natriuretic peptide (BNP) level predicts long term ventricular arrhythmias in patients with moderate to severe left ventricular dysfunction]. Harefuah 2012 0.75
66 Percutaneous coronary intervention in a patient with factor XI deficiency. J Invasive Cardiol 2009 0.75